247 related articles for article (PubMed ID: 25266181)
1. Clinical and molecular characterization of maturity onset-diabetes of the young caused by hepatocyte nuclear factor-4 alpha mutation: red flags for prediction of the diagnosis.
Mohamed S; Elkholy S; El-Meleagy E; Abu-Amero K; Hellani AM
Ann Saudi Med; 2014; 34(3):217-21. PubMed ID: 25266181
[TBL] [Abstract][Full Text] [Related]
2. Systematic assessment of etiology in adults with a clinical diagnosis of young-onset type 2 diabetes is a successful strategy for identifying maturity-onset diabetes of the young.
Thanabalasingham G; Pal A; Selwood MP; Dudley C; Fisher K; Bingley PJ; Ellard S; Farmer AJ; McCarthy MI; Owen KR
Diabetes Care; 2012 Jun; 35(6):1206-12. PubMed ID: 22432108
[TBL] [Abstract][Full Text] [Related]
3. Identification of HNF1A-MODY and HNF4A-MODY in Irish families: phenotypic characteristics and therapeutic implications.
Kyithar MP; Bacon S; Pannu KK; Rizvi SR; Colclough K; Ellard S; Byrne MM
Diabetes Metab; 2011 Dec; 37(6):512-9. PubMed ID: 21683639
[TBL] [Abstract][Full Text] [Related]
4. Urinary C-peptide creatinine ratio is a practical outpatient tool for identifying hepatocyte nuclear factor 1-{alpha}/hepatocyte nuclear factor 4-{alpha} maturity-onset diabetes of the young from long-duration type 1 diabetes.
Besser RE; Shepherd MH; McDonald TJ; Shields BM; Knight BA; Ellard S; Hattersley AT
Diabetes Care; 2011 Feb; 34(2):286-91. PubMed ID: 21270186
[TBL] [Abstract][Full Text] [Related]
5. Clinical and laboratory clues of maturity-onset diabetes of the young and determination of association with molecular diagnosis.
Karaoglan M; Nacarkahya G
J Diabetes; 2021 Feb; 13(2):154-163. PubMed ID: 32710514
[TBL] [Abstract][Full Text] [Related]
6. Digenic heterozygous HNF1A and HNF4A mutations in two siblings with childhood-onset diabetes.
Shankar RK; Ellard S; Standiford D; Pihoker C; Gilliam LK; Hattersley A; Dolan LM
Pediatr Diabetes; 2013 Nov; 14(7):535-8. PubMed ID: 23551881
[TBL] [Abstract][Full Text] [Related]
7. Mutations in the genes encoding the transcription factors hepatocyte nuclear factor 1 alpha (HNF1A) and 4 alpha (HNF4A) in maturity-onset diabetes of the young.
Ellard S; Colclough K
Hum Mutat; 2006 Sep; 27(9):854-69. PubMed ID: 16917892
[TBL] [Abstract][Full Text] [Related]
8. Prevalence, characteristics and clinical diagnosis of maturity onset diabetes of the young due to mutations in HNF1A, HNF4A, and glucokinase: results from the SEARCH for Diabetes in Youth.
Pihoker C; Gilliam LK; Ellard S; Dabelea D; Davis C; Dolan LM; Greenbaum CJ; Imperatore G; Lawrence JM; Marcovina SM; Mayer-Davis E; Rodriguez BL; Steck AK; Williams DE; Hattersley AT;
J Clin Endocrinol Metab; 2013 Oct; 98(10):4055-62. PubMed ID: 23771925
[TBL] [Abstract][Full Text] [Related]
9. Onset of type 1 diabetes mellitus in two patients with maturity onset diabetes of the young.
Maltoni G; Zucchini S; Scipione M; Mantovani V; Salardi S; Cicognani A
Pediatr Diabetes; 2012 Mar; 13(2):208-12. PubMed ID: 21696527
[TBL] [Abstract][Full Text] [Related]
10. Maturity Onset Diabetes of the Young due to Glucokinase, HNF1-A, HNF1-B, and HNF4-A Mutations in a Cohort of Turkish Children Diagnosed as Type 1 Diabetes Mellitus.
Ozsu E; Cizmecioglu FM; Yesiltepe Mutlu G; Yuksel AB; Calıskan M; Yesilyurt A; Hatun S
Horm Res Paediatr; 2018; 90(4):257-265. PubMed ID: 30481753
[TBL] [Abstract][Full Text] [Related]
11. Familial young-onset forms of diabetes related to HNF4A and rare HNF1A molecular aetiologies.
Carette C; Dubois-Laforgue D; Saint-Martin C; Clauin S; Beaufils S; Larger E; Sola A; Mosnier-Pudar H; Timsit J; Bellanné-Chantelot C
Diabet Med; 2010 Dec; 27(12):1454-8. PubMed ID: 21105491
[TBL] [Abstract][Full Text] [Related]
12. Screening of HNF1A and HNF4A mutation and clinical phenotype analysis in a large cohort of Chinese patients with maturity-onset diabetes of the young.
Wang X; Wang T; Yu M; Zhang H; Ping F; Zhang Q; Xu J; Feng K; Xiao X
Acta Diabetol; 2019 Mar; 56(3):281-288. PubMed ID: 30293189
[TBL] [Abstract][Full Text] [Related]
13. Maturity onset diabetes of the young: identification and diagnosis.
McDonald TJ; Ellard S
Ann Clin Biochem; 2013 Sep; 50(Pt 5):403-15. PubMed ID: 23878349
[TBL] [Abstract][Full Text] [Related]
14. Mutations in the genes encoding the transcription factors hepatocyte nuclear factor 1 alpha and 4 alpha in maturity-onset diabetes of the young and hyperinsulinemic hypoglycemia.
Colclough K; Bellanne-Chantelot C; Saint-Martin C; Flanagan SE; Ellard S
Hum Mutat; 2013 May; 34(5):669-85. PubMed ID: 23348805
[TBL] [Abstract][Full Text] [Related]
15. [Clinical parameters for molecular testing of Maturity Onset Diabetes of the Young (MODY)].
Datz N; Nestoris C; von Schütz W; Danne T; Driesel AJ; Maringa M; Kordonouri O
Dtsch Med Wochenschr; 2011 May; 136(21):1111-5. PubMed ID: 21590629
[TBL] [Abstract][Full Text] [Related]
16. Hepatocyte nuclear factor (HNF)1A and HNF4A substitution occurring simultaneously in a family with maturity-onset diabetes of the young.
Beijers HJ; Losekoot M; Odink RJ; Bravenboer B
Diabet Med; 2009 Nov; 26(11):1172-4. PubMed ID: 19929997
[TBL] [Abstract][Full Text] [Related]
17. Novel presentations of congenital hyperinsulinism due to mutations in the MODY genes: HNF1A and HNF4A.
Stanescu DE; Hughes N; Kaplan B; Stanley CA; De León DD
J Clin Endocrinol Metab; 2012 Oct; 97(10):E2026-30. PubMed ID: 22802087
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis of hepatic nuclear factor 1A monogenic diabetes mellitus (HNF1A-MODY) impacts antihyperglycemic treatment.
Schnedl WJ; Holasek SJ; Schenk M; Enko D; Mangge H
Wien Klin Wochenschr; 2021 Mar; 133(5-6):241-244. PubMed ID: 33245425
[TBL] [Abstract][Full Text] [Related]
19. Identification of HNF4A Mutation p.T130I and HNF1A Mutations p.I27L and p.S487N in a Han Chinese Family with Early-Onset Maternally Inherited Type 2 Diabetes.
Yang Y; Zhou TC; Liu YY; Li X; Wang WX; Irwin DM; Zhang YP
J Diabetes Res; 2016; 2016():3582616. PubMed ID: 26981542
[TBL] [Abstract][Full Text] [Related]
20. Maturity-onset diabetes of the young (MODY): an update.
Anık A; Çatlı G; Abacı A; Böber E
J Pediatr Endocrinol Metab; 2015 Mar; 28(3-4):251-63. PubMed ID: 25581748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
